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quence identity and have about 25% identity with a putative
phosphate permease of Neurospora crassa (10, 11, 14, 15).
These data suggested that Glvr-1 and Ram-1 might be transporters; however, their solute specificities could not be
inferred because even closely related transport proteins often
carry unrelated solutes (12, 13, 16, 17).
We identified the transporter activities of Glvr-i and Ram-1
by a systematic approach that involved expression of these
proteins in Xenopus laevis oocytes and measurement of
transmembrane currents during exposure of the oocytes to
different salts and nutrients. Our results indicate that Glvr-1
and Ram-1 are sodium/phosphate symporters and that these
proteins provide a major pathway for phosphate uptake into
many mammalian cells. In addition, we have shown that
phosphate transport rates are affected both by retroviral
infection and by changes in extracellular phosphate levels.

Cell surface receptors for gibbon ape leukeABSTRACT
mia virus (Glvr-1) and marine amphotropic retrovirus (Ram-i)
are distinct but related proteins having multiple membranenning regions. Distant homology with a putative phosphate
permease of Neurospora crussa suggested that these receptors
might serve transport functions. By expression in Xenopus
laevis oocytes and in mam l cells, we have identified
Glvr-1 and Ram-i as sodium-dependent phosphate symporters. Two-electrode voltage-camp analysis indicates net cation
influx, gestng that phosphate is transported with excess
sodium ions. Phosphate uptake was reduced by >50% in
mouse fibroblasts expressing amphotropic envelope glycoprotein, which binds to Ram-i, indicating that Ram-i Is a major
phosphate transporter in these cells. RNA analysis shows wide
but distinct tissue distributions, with Glvr-1 expression being
highest in bone marrow and Ram-i in heart. Overexpression of
Ram-i severely reprsd Glvr-i synthesis in fibroblasts, suggesting that transporter expression may be controlled by net
phosphate accumulation. Accordingly, depletion of extracellular phosphate increased Ram-i and Glvr-i expression 3- to
5-fold. These results suggest simple methods to modulate
retroviral receptor expression, with possible applications to
human gene therapy.

MATERIALS AND METHODS
Cell Lines and Retroviral Vectors. Cell lines used included
208F rat embryo fibroblasts (18), PA317 cells (19), and NIH
3T3 thymidine kinase-minus mouse embryo fibroblasts (20)
and derivatives. Cells were grown in Dulbecco's minimal
essential medium with 10%o (vol/vol) fetal bovine serum.
Retroviral vectors encoding neomycin phosphotransferase
and rat Ram-1, human Glvr-1, the mouse ecotropic receptor
Rec-i, or human clotting factor IX were made by cloning the
respective cDNAs into the retroviral vector LXSN (21).
Vectors were transfected into PA317 retrovirus packaging
cells (19), and transiently produced virus was harvested after
2 days and was used to transduce 208F rat fibroblasts as
described (21) except for the clotting factor IX virus, which
was harvested from a previously described stable vectorproducing cell line (22). Transduced cells were grown in the
presence of G418 to select for cells expressing the vectors.
Ion-Transport Assays in Xenopus Oocytes Injected with
Retrovirus Receptor RNAs. The coding regions of the rat
Ram-i (10) and human Glvr-1 (7) cDNAs were cloned into
pGEM-7Z (Promega) with their 5' ends adjacent to the SP6
promoter. For mRNA synthesis, the plasmids were linearized and transcribed with SP6 polymerase in the presence of
m7G(5')ppp(5')G caps according to the manufacturer's directions (Pharmacia). Xenopus laevis oocytes were injected with
50 nl of mRNA (1 ng/nl) or with an equal volume of H20 and
were incubated for 4-6 days at 17'C; then two-microelectrode voltage-clamp recordings or radiolabel uptake assays
were performed at room temperature as described (23).

Key issues in virology have been identification of cell-surface
virus receptors, determination of receptor expression patterns, and elucidation of the effects of infection on the normal
functions of these molecules. These issues are critical in the
case of retroviruses because cells can become chronically
infected, leading to receptor down-modulation and subsequent derangements in cellular functions. For example, the
CD4 receptor for human immunodeficiency virus (HIV) is
important for helper T-cell function, and interference with
this normal function is an important aspect of HIV-induced
disease (1). Indeed, three genes of HIV (env, nef, and vpu)
can each mediate CD4 down-modulation (1-4).
While several retroviral receptor cDNAs have been isolated (5-11), the only functionally characterized receptors are
the above-mentioned CD4 for HIV and a sodium-independent cationic amino acid transporter for ecotropic murine
leukemia viruses (MLVs) (12, 13). Among the cloned receptors with unknown functions are those that mediate infections
of gibbon ape leukemia virus (GALV) and of mouse amphotropic retrovirus (these receptors are termed Glvr-1 and
Ram-1, respectively) (7, 10, 11). Glvr-1 and Ram-1 are
distinct proteins with multiple hydrophobic potential membrane-spanning sequences. Although they contain large unrelated central domains, they share about 60% overall se-

Abbreviations: GALV, gibbon ape leukemia virus; Glvr-1, cell
surface receptor for GALV; Ram-i, cell surface receptor for amphotropic murine retrovirus; HIV, human immunodeficiency virus;
MLV, murine leukemia virus; Mo-MLV, Moloney MLV.
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Voltage clamp recordings were made at -60 mV in recording
solution containing 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2,
1 mM MgCl2, and 5 mM Hepes (pH 7.5). Sodium-free
recordings and uptake assays were made by replacement of
Na+ with Tris+. Uptake measurements at pH 8.5 were in
solution buffered with 5 mM Hepes containing Tris. For
phosphate-uptake assays, carrier-free H332PO4 (Amersham)
was adjusted to 10 Ci (370 GBq) per ml by using unlabeled
sodium phosphate (pH 7.5). Uptake of [32P]phosphate was
found to be linear for >2 hr. After 30-60 min of uptake,
oocytes were washed three times, lysed with 1% SDS, and
analyzed for radioactivity by liquid-scintillation spectroscopy. [32P]Phosphate uptake rates are given in pmol/min per
oocyte. The transport kinetic parameters were determined by
least-squares fitting data points representing the average
uptake from three or four oocytes to the Michaelis-Menten
expression. Km values expressed are the average of values
determined in four separate experiments.
Phosphate Transport Assays in Mammalian Cells. Mammalian cells were seeded at 2-4 x 105 cells per 3.5-cm-diameter
dish in medium with or without phosphate. Phosphate transport was measured 1 day later as follows. The culture medium
was replaced with phosphate-free medium (Dulbecco's minimal essential medium without phosphate plus 5% dialyzed
fetal bovine serum) supplemented with [32P]phosphate at five
concentrations from 10 ,pM to 1 mM. Each dish of cells was
exposed to an equal concentration of [32P]phosphate (9000
Ci/mmol of H332P04 in water; NEN/DuPont) plus unlabeled
phosphate (K2HPO4/KH2PO4, pH 7.5) to achieve the required total phosphate concentration. After 20 min of incubation at 37TC in a 5% C02/95% air atmosphere (medium pH
= 7.5), the cells were washed twice with ice-cold phosphatebuffered saline and solubilized in 0.5% sodium dodecyl
sulfate, after which portions were analyzed for radioactivity
by scintillation spectroscopy and for protein by the fluoraldehyde protein assay (Pierce). Phosphate uptake was linear
over 1 hr under these conditions.
RNA Preparation. Rat tissues were rapidly frozen after
dissection, except for bone marrow and spleen from which

A

single-cell suspensions were prepared. RNA was prepared
from frozen tissues by the guanidine thiocyanate-phenol/
chloroform extraction procedure (24) after tissue homogenization in guanidine thiocyanate by using a Polytron homogenizer (Brinkmann). RNA was prepared from spleen and
bone marrow cells and from cultured cell lines by using a
guanidine thiocyanate lysis/LiCl precipitation procedure
(25). RNAs were stored in water at -70°C.

RESULTS
Ram-l and Glvr-1 Transport Phosphate In Oocytes and in
ammaan Cells. To determine the normal functions of
Glvr-1 and Ram-1, we prepared and injected capped synthetic
mRNA into Xenopus laevis oocytes and screened for electrogenic transport activity by exposure of voltage-clamped
oocytes to potential substrates. No specific currents were
obtained with mixtures of vitamins, amino acids, or other
common nutrients. However, an inward current was observed when oocytes injected with Glvr-1 mRNA were
exposed to phosphate. This inward current was absent in
oocytes injected with H20 (Fig. 1A) or an irrelevant RNA
encoding the human glutamate transporter (data not shown)
and was abolished when extracellular sodium was replaced
by Tris (Fig. 1A). Similar but smaller sodium-dependent
phosphate currents were observed in oocytes injected with
synthetic Ram-i mRNA (data not shown).
Measurement of [32P]phosphate uptake into oocytes expressing Ram-i or Glvr-1 was used to examine the transporters' specificity, sodium requirements, pH dependence, and
concentration dependence. Fig. 1B shows phosphate uptake
into oocytes expressing Ram-i or Glvr-1 in comparison with
uptake into H20-injected oocytes. Uptake of phosphate
mediated by both transporters was nearly abolished when
extracellular sodium was replaced by Tris (Fig. 1B). The
concentration dependence of phosphate uptake behaved in
accord with Michaelis-Menten kinetics: for Glvr-1 the Km
was 24.1 ± 5.5 ,uM (n = 4), and for Ram-1 the Km was 25.3
± 6.0 ,uM (n = 4) (Fig. 1C). Uptake of 10 ,M phosphate by

Glvr-1
Na1
1 00

(1994)

control

P

'um Pi

10 nA
30 sec

B

C
. 1.2

GIvr- -

E

u-

Q-

0.8.

_o

0.6

0-

0i6 j
0.

0- 04

0.
co

Rm1

Gv-.
CL-

0.2
O 1.

(Na

Cont o(

1
a[>
~~~~~Rar-

021t
I

..H20
50

100

150
"

200 250

300

pM

FIG. 1. Phosphate uptake induced by injectionofGlvr-l and Ram-l mRNA into Xenopus oocytes. (A) Two-electrode voltage-clamp recording
of oocytes injected with Glvr-1 mRNA (Left) or H20 (Right). The inward current evoked in the cells expressing Glvr-1 by application of 100
pM phosphate (solid bar) is dependent on sodium (hollow bar). No phosphate-dependent currents were seen in water-injected oocytes (Right).
Voltage-clamp recordings were performed with a holding potential of -60 mV. (B) Uptake of 100 pM [32P]phosphate into Xenopus oocytes
injected with Glvr-1 or Ram-i mRNA. Oocytes were incubated in recording solution containing [32P]phosphate for 60 min followed by lysis and
scintillation spectroscopy. Uptake rates are given per oocyte. (C) Concentration-dependence of [32P]phosphate uptake. Points (mean ± SEM,
n = 4) were fitted by least squares to a function of the form V = [Vma.[Pd/(Km + [Pid)].
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oocytes expressing Ram-i or Glvr-1 was not significantly
inhibited by a 10-fold excess of unlabeled sulfate [133 ± 24%
and 81 ± 13% ofcontrol, respectively (n = 3)], demonstrating
a specificity for phosphate over sulfate. Increasing pH inhibited uptake mediated by both Ram-i and Glvr-1. At pH
8.5, the uptake of 10 pM phosphate was 41 ± 13% and 55 +
4% of the respective uptake rates at pH 7.5 (n = 3).
We extended these results by using mammalian cells. Rat
fibroblasts transduced with retroviral vectors encoding
Ram-1 and Glvr-1 exhibited 3- to 5-fold higher rates of
phosphate uptake compared with unmodified cells or cells
transduced with vectors encoding other proteins (Fig. 2). Km
values for receptor-specific phosphate uptake were 200 pM
(Ram-i) and 70 1AM (Glvr-1) (n = 2), similar to previous
values for mammalian cells (26, 27). Differences between
these values and those obtained in oocytes could result from
uncontrolled variables, such as membrane potential or posttranslational receptor modifications.
Amphotrpk Retrovirus Envelope Expression Inhibits Phosphate Transport. We examined phosphate transport in cell
lines that expressed different retroviral Env proteins (Fig. 3).
All cell lines were derived from the same NIH 3T3 thymidine
kinase-minus cell parent, and all expressed Mo-MLV retrovirus Gag-Pol proteins. Phosphate transport was reduced by
50-60%6 in mouse fibroblasts that expressed amphotropic
Env compared with cells that expressed no Env. Phosphate
transport was unaffected in cells expressing the ecotropic
Env protein, as expected because ecotropic retroviruses
interact with a different cellular receptor that transports basic
amino acids (12, 13). Little or no effect on phosphate transport was observed in cells expressing the GALV Env protein.
The latter result was anticipated because GALV cannot
infect mouse cells, presumably because of an inability to bind
the murine Glvr-1 protein (30). These results suggest that
Ram-1 is a major phosphate transporter in fibroblasts and that
its function is specifically inhibited in infected cells by
binding of the amphotropic envelope glycoprotein. This
inhibition could be due to direct interference of the Env
protein with phosphate transport or to effects on Ram-1
synthesis or degradation. Similar reductions in cell-surface
receptor levels are caused by retroviral envelope glycoproteins in cells infected with HIV (2) or ecotropic mouse
retroviruses (31).
160

70

. 60
iD
0

50- IV

C

Q. 40- I-

^30-

in~ ~ ~

0

E 20-

I100-

ENV:

NONE

ECO

GALV AMPHO

To provide direct evidence for binding of amphotropic Env
protein to Ram-i, we measured binding of gp7O Env protein
from amphotropic virus 4070A to CHO cells that express
Ram-i. CHO cells are normally resistant to infection by
amphotropic retroviruses or retroviral vectors but can be
made susceptible by transfer of Ram-i from a susceptible
species (10, 11). Binding of gp70 Env protein was measured
by incubation of cells with gp70 followed by antiserum to
gp70 and by 125I-labeled protein A as described (13, 32). Three
independent CHO cell clones that were transduced with a
retroviral vector that expresses rat Ram-i showed binding of
8400 2100, 8200 600, and 6300 400 cpm/mg of protein
(n = 2) compared with 1030 270 cpm/mg of protein (n =
4) for control CHO cells. These results indicate direct binding
of amphotropic envelope protein to Ram-1.
Regulaton of Phosphate Uptake In Cultured Ceib. Phosphate transporter synthesis increases in response to reduced
extracellular phosphate levels in bacteria (33) and fungi (14,
34), suggesting the possibility of similar regulation in mammalian cells. Indeed, exposure of 208F rat fibroblasts to
phosphate-free medium for 24 hr resulted in a 3-fold increase
in phosphate transport [V.. = 121 + 9 without phosphate
2 with phosphate (n = 2)], which was accomversus 39
panied by a 3- to 5-fold increase in both Ram-1 and Glvr-1
RNA levels (Fig. 4 Left). Overexpression of Ram-1 in 208F
cells following transduction with the LrRAMSN vector (Fig.
4 Left Upper) resulted in suppression of Glvr-i RNA expression by 80%o (Fig. 4 Left Lower). These results demonstrate
both positive and negative regulation of Ram-i and Glvr-1,
presumably in response to intracellular phosphate levels.
Differental Expession of Ram-1 and Glvr-1 RNAs In Animal Ties. Levels of virus receptor expression in different
tissues influence the course of retroviral disease and are an
important parameter for gene transduction studies, especially
in the case of gene therapy. Ram-i and Glvr-1 have broad but
distinct tissue distributions (Fig. 4 Right). Expression ofboth
Ram-i and Glvr-i RNAs was detected in all tissues except
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FIG. 2. Ram-1 and Glvr-1 cause increased phosphate transport in
cultured 208F rat embryo fibroblasts. Retroviral vectors encoding
neomycin phosphotransferase and rat Ram-1, human Glvr-1, mouse
ecotropic receptor Rec-i, or human clotting factor IX (FIX) were
expressed in rat 208F cells that were used for transport analysis.
Eadie-Hofstee plots of phosphate uptake velocity (V) versus the
velocity/phosphate concentration ratio (V/[PI) are shown. The Y
axis regression line intercept gives the V. for phosphate transport,
and the slope is equal to -Km.

AMPHO2

FIG. 3. Expression of amphotropic Env protein inhibits phosphate transport in NIH 3T3 mouse fibroblasts. Phosphate transport
(V..) was determined for NIH 3T3 cells expressing Moloney MLV
(Mo-MLV) Gag-Pol proteins and the indicated Env glycoproteins.
Cell lines used were GP91-22 cells expressing no Env (NIH 3T3 cells
transfected with an Mo-MLV Gag-Pol expression plasmid) (28), NIH
3T3/Mo-MLV cells expressing ecotropic (ECO) env (NIH 3T3 cells
transfected with the replication-competent Mo-MLV clone
pMLV-K) (29), PG13 cells expressing GALV Env (GP91-22 cells
transfected with a GALV Env expression plasmid) (28), NIH 3T3/
AM-MLV cells expressing an amphotropic (AMPHO1) Env (NIH
3T3 cells transfected with hybrid Mo-MLV Gag-Pol/ampho 4070A
Env replication-competent retrovirus plasmid pAM-MLV) (19), and
PA317 cells expressing an amphotropic (AMPHO2) Env (NIH 3T3
cells transfected with a hybrid Mo-MLV Gag-Pol/ampho 4070A Env
replication-incompetent expression plasmid) (19).
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FIG. 4. Ram-i and Glvr-1 RNA expression analysis. Probes for
Ram-1 (Hae II to BamHI, 560 bp) and Glvr-1 (Nco I to Nco I, 583
bp) were obtained from the nonhomologous central regions of the rat
Ram-i (10) and mouse Glvr-1 (15) cDNA clones. The observed sizes
of the Ram-1 and Glvr-1 mRNAs are both about 4 kb by comparison
to ethidium bromide-stained ribosomal RNAs (not shown), while the
predicted and observed size of the LrRAMSN (retroviral vector
encoding rat Ram-1) RNA is about 5.3 kb. (Left) RNA was prepared
from 208F rat fibroblasts grown for 24 hr in medium with or without
1 mM phosphate or from 208F cells transduced with LrRAMSN and
grown in the presence of 1 mM phosphate. Samples (10 gg) were
analyzed by using probes for Ram-1 (Upper) and Glvr-i (Lower).
Ethidium bromide staining ofrRNA confirmed equal sample loading.
Radioactivity associated with each band was quantitated by phosphor imaging. (Right) Expression of Ram-i and Glvr-i RNA in rat
tissues. RNA was isolated from the indicated rat tissues, and 20 yg
samples were subjected to Northern analysis. The same blot was
probed with Ram-1 (Upper), then stripped, and reprobed with Glvr-i
(Lower). Ethidium bromide staining of ribosomal RNAs revealed
uniform RNA loading except for the muscle and spleen samples
where the total rRNA levels were about one-third of those for the
other lanes.

spleen. Differential expression was most evident in bone
which contains little Ram-1 but abundant Glvr-i,
and in heart, where the opposite was true.
marrow,

DISCUSSION
We conclude that two retroviral receptors, Glvr-i and Ram-i,
are sodium-dependent phosphate transporters in a wide range
of maalian cells. Their roles in phosphate transport are
suggested by expression studies in Xenopus oocytes and
mammalian cells, by the specific inhibition of phosphate
uptake that occurs in mouse fibroblasts after expression of
amphotropic envelope glycoproteins, and by increases in
Glvr-i and Ram-i expression that accompany removal of
extracellular phosphate from cultured fibroblasts. Phosphate
is a critical nutrient for cells and is required for nucleic acid
and lipid synthesis, energy metabolism, signal transduction,
and regulation of protein enzymatic activities.
An important feature of this study is the use of Xenopus
oocytes in voltage-clamp conditions and the screening of
potential transport solutes by measurements of currents.
Under voltage-clamp conditions, exposure of oocytes expressing Glvr-i or Ram-i to phosphate resulted in inward
currents, demonstrating that these transporters are electrogenic and mediate net cation influx. Removal of external
sodium abolished the phosphate-dependent inward current,
in accord with the observed sodium dependence for uptake of
[32P]phosphate (Fig. 1). These properties ofGlvr-i and Ram-i
indicate that they mediate the coupled influx of a stoichiometric excess of sodium relative to phosphate. This result is
in agreement with the general finding that the electrochemical
gradient of sodium is the major driving force for phosphate
uptake across the plasma membrane of animal cells, while
phosphate uptake in prokaryotes, plant cells, and mitochondria is driven by a proton gradient (26). Mammalian cell

(1994)

internal phosphate levels (75 milliequivalents per liter) are
maintained at about 10-fold higher levels than external levels
(4 milliequivalents per liter) in opposition to an electrochemical gradient that favors anion movement out of cells. Further
studies will be required to determine whether the increased
phosphate uptake at pH 7.5 relative to 8.5 is due to preferential uptake of a protonated form of phosphate or to direct
effects on the transporter.
Sodium-dependent phosphate transporters (NaPi-1, -2, -3,
and 4) have been cloned from rabbit, rat, human, and
opposum kidney (35-37). NaPi-2, -3, and 4 are homologous
transporters from different species, while NaPi-1 is unrelated
to the others at the sequence level. These transporters are
localized to proximal tubulbs of kidney cortex and are
believed to mediate phosphate reuptake from glomerular
filtrates at the polarized epithelial brush border membranes.
Although these transporters display a substrate specificity
and phosphate uptake affinity similar to Glvr-1 and Ram-i,
they exhibit no sequence similarity. In addition, phosphate
uptake mediated by the kidney transporters is increased at
elevated pH (36), while uptake mediated by Glvr-i or Ram-i
is decreased. Based on the relatively broad tissue distributions of Glvr-i and Ram-1, we propose that these retroviral
receptors are likely to be the major carriers of phosphate from
interstitial fluids into most cell types, in contrast with the
renal transporters that exhibit a discrete localization at the
apical membranes of epithelial cells. The hypothesis that
Glvr-1 and Ram-1 are major phosphate transporters is supported by the substantial down-modulation of phosphate
uptake that occurs in mouse fibroblasts expressing amphotropic envelope glycoproteins and by the large coinductions
of phosphate transport and of Glvr-1 and Ram-i mRNA
levels in cultured fibroblasts deprived of extracellular phosphate. Phosphate transport in perfused rat heart (38) is
dependent on extracellular sodium and exhibits a Km for
phosphate of 240 pAM, similar to the sodium requirement, and
200 pM Km for phosphate uptake found here for Ram-1,
supporting the hypothesis that Ram-1 is a major phosphate
transporter in the heart.
The broad tissue distributions ofGlvr-1 and Ram-1 are also
consistent with their roles in mediating blood-borne infections of multiple tissues. For example, GALV has been
isolated from brains and hematopoietic tissues of infected
animals and has been associated with induction of leukemias
in gibbon apes (39, 40). Feline leukemia virus subgroup B,
which also depends on the Glvr-1 receptor for binding and
entry into cells (41), is cytopathic for feline bone marrow cells
in vitro and has been associated with lymphoma, sarcoma,
and myeloproliferative diseases (42-44). It is interesting to
speculate that infections might cause severe phosphate deprivations with pathological consequences, especially in cells
that rely heavily on the transporter that is used by the specific
virus. The pattern of Glvr-1 RNA expression that we find is
consistent with a previous study that found high levels of
Glvr-i expression in brain and thymus (15), but in that study
bone marrow was not examined.
These results also have important implications for gene
therapy. While mouse hematopoietic stem cells can be efficiently transduced by using ecotropic retroviral vectors,
these vectors do not infect human cells, and commonly used
amphotropic vectors infect primate hematopoietic stem cells
far less efficiently (45). Our findings that Ram-1 is poorly
expressed in bone marrow while Glvr-i expression is highest
in this tissue suggest that GALV-based vectors may allow
more efficient gene transfer into bone marrow hematopoietic
cells, and preliminary data showing a 2- to 3-fold improvement in the transduction rate of human granulocyte/
macrophage colony-forming cells support this conclusion

(46).
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